Takeda's hyqvia® approved by european commission as maintenance therapy in patients with chronic inflammatory demyelinating polyneuropathy (cidp)

Osaka, japan & cambridge, mass.--(business wire)--takeda announced that the ec approved hyqvia as maintenance therapy in patients of all ages with cidp after stabilization with ivig.
TAK Ratings Summary
TAK Quant Ranking